Contact
searchSearch
HMP Global

March 2011 - FRMC

Feature
Metformin Use and Mortality among Patients with Diabetes and Atherothrombosis
03/21/2011
The most common cause of death among patients with type 2 diabetes mellitus is cardiovascular disease. While progress has been made in establishing preventive care among this population, there is still an excess of deaths associated with...
The most common cause of death among patients with type 2 diabetes mellitus is cardiovascular disease. While progress has been made in establishing preventive care among this population, there is still an excess of deaths associated with...
The most common cause of death...
03/21/2011
First Report Managed Care
Feature
Visits to the ED for AEs Related to Hemorrhage in Patients Receiving Dual Antiplatelet Therapy
03/21/2011
For patients with cardiovascular disease, standard of care is dual antiplatelet therapy (DAT) with clopidogrel plus aspirin.
For patients with cardiovascular disease, standard of care is dual antiplatelet therapy (DAT) with clopidogrel plus aspirin.
For patients with cardiovascular...
03/21/2011
First Report Managed Care
Feature
Depression and Diabetes in Women: A Bidirectional Association
03/21/2011
More than 10% of the adults in the United States have diabetes; in those aged ≥60 years of age, the prevalence is 23%. Approximately 14.8 million Americans aged ≥18 years are affected by major depressive disorder (MDD) in a given year. The...
More than 10% of the adults in the United States have diabetes; in those aged ≥60 years of age, the prevalence is 23%. Approximately 14.8 million Americans aged ≥18 years are affected by major depressive disorder (MDD) in a given year. The...
More than 10% of the adults in...
03/21/2011
First Report Managed Care
Feature
Mohs Micrographic Surgery in Medicare Population
03/18/2011
New Orleans—Between 2001 and 2006 the number of patients in the Medicare population receiving Mohs micrographic surgery (MMS) for nonmelanoma skin cancer (NMSC) doubled, according to a retrospective review of Medicare patients receiving...
New Orleans—Between 2001 and 2006 the number of patients in the Medicare population receiving Mohs micrographic surgery (MMS) for nonmelanoma skin cancer (NMSC) doubled, according to a retrospective review of Medicare patients receiving...
New Orleans—Between 2001 and...
03/18/2011
First Report Managed Care
Feature
Regression in Melanoma
03/18/2011
New Orleans—According to an analysis of the National Cancer Institute’s Surveillance, Epidemiology, and End Results (SEER) program from 1973 through 2006, patients with regressing melanoma had a higher survival rate than those with...
New Orleans—According to an analysis of the National Cancer Institute’s Surveillance, Epidemiology, and End Results (SEER) program from 1973 through 2006, patients with regressing melanoma had a higher survival rate than those with...
New Orleans—According to an...
03/18/2011
First Report Managed Care
Feature
Briakinumab Superior to Placebo in Three Phase 3 Trials
03/18/2011
New Orleans—A pooled analysis of three phase 3, randomized, double-blind, placebo-controlled trials of patients with moderate-to-severe psoriasis found that patients taking briakinumab had superior results to those taking placebo as measured...
New Orleans—A pooled analysis of three phase 3, randomized, double-blind, placebo-controlled trials of patients with moderate-to-severe psoriasis found that patients taking briakinumab had superior results to those taking placebo as measured...
New Orleans—A pooled analysis of...
03/18/2011
First Report Managed Care
Feature
Tofacitinib Improves Pruritus Severity
03/18/2011
New Orleans—A 12-week, double-blind, placebo-controlled, phase 2b study found that patients with psoriasis who took tofacitinib had sustained clinically meaningful improvement in pruritus severity. Carla Mamolo, PhD, associate director of...
New Orleans—A 12-week, double-blind, placebo-controlled, phase 2b study found that patients with psoriasis who took tofacitinib had sustained clinically meaningful improvement in pruritus severity. Carla Mamolo, PhD, associate director of...
New Orleans—A 12-week,...
03/18/2011
First Report Managed Care
Feature
Adalimumab More Effective, Less Costly than Etanercept
03/18/2011
New Orleans—An analysis of adult patients with moderate-to-severe psoriasis found that those treated with adalimumab had significantly fewer medical services and significantly lower pharmacy costs and medical services costs compared with...
New Orleans—An analysis of adult patients with moderate-to-severe psoriasis found that those treated with adalimumab had significantly fewer medical services and significantly lower pharmacy costs and medical services costs compared with...
New Orleans—An analysis of adult...
03/18/2011
First Report Managed Care
Feature
Cardiovascular Events Similar Between Ustekinumab, Placebo
03/18/2011
New Orleans—Patients taking ustekinumab for ≤3 years had similar rates of serious and nonserious cardiovascular (CV) events compared with a placebo group, according to a pooled analysis of phase 2 and 3 trials. Kenneth B. Gordon, MD, medical...
New Orleans—Patients taking ustekinumab for ≤3 years had similar rates of serious and nonserious cardiovascular (CV) events compared with a placebo group, according to a pooled analysis of phase 2 and 3 trials. Kenneth B. Gordon, MD, medical...
New Orleans—Patients taking...
03/18/2011
First Report Managed Care

Department

News Connection
Nearly a Quarter of Americans Think the Healthcare Reform Law Has Been Repealed
03/18/2011
The most recent Kaiser Family Foundation health tracking poll, conducted in the wake of the healthcare reform repeal vote in the US House of Representatives, found that 22% of Americans believe that the Patient Protection and Affordable Care...
The most recent Kaiser Family Foundation health tracking poll, conducted in the wake of the healthcare reform repeal vote in the US House of Representatives, found that 22% of Americans believe that the Patient Protection and Affordable Care...
The most recent Kaiser Family...
03/18/2011
First Report Managed Care
FRMC Volume 21, Issue 3

Current Issue

September 2024
Volume 21
Issue 3
Current Issue
Issue Archive

What's Trending?

Zolpidem Tartrate Sublingual Tablets to Treat Insomnia
08/16/2012
Boston—According to a post hoc analysis of a double-blind, placebo-controlled cross-over study, patients who took 1.75 mg and 3.5 mg of zolpidem tartrate sublingual tablets had a significantly shorter time to sleep compared with those who...
Boston—According to a post hoc analysis of a double-blind, placebo-controlled cross-over study, patients who took 1.75 mg and 3.5 mg of zolpidem tartrate sublingual tablets had a significantly shorter time to sleep compared with those who...
Boston—According to a post hoc...
08/16/2012
First Report Managed Care
News
Report outlines possible savings for Medicaid
05/09/2011
05/09/2011
First Report Managed Care
News
CMS Issues Rules on Loss Ratios for Medicare Plans
02/19/2013
02/19/2013
First Report Managed Care
News
Obama Says His Departure May Fix What Ails Obamacare
10/20/2016
President Barack Obama recently spoke in Florida, and said that his departure from office in January might be what it takes to begin to reverse the political scars over the Affordable Care Act and allow for needed fixes to his signature...
President Barack Obama recently spoke in Florida, and said that his departure from office in January might be what it takes to begin to reverse the political scars over the Affordable Care Act and allow for needed fixes to his signature...
President Barack Obama recently...
10/20/2016
First Report Managed Care

Video Insights

Videos
Bridging the Gaps in Prior Authorization: Challenges, Solutions, and Collaboration for Better Patient Care
11/13/2024
David Sand, MD, MBA, chief medical officer at ZeOmega, discusses the challenges of prior authorization, emphasizing the need for transparency, evidence-based standards, collaboration between payers and providers, and the potential for...
David Sand, MD, MBA, chief medical officer at ZeOmega, discusses the challenges of prior authorization, emphasizing the need for transparency, evidence-based standards, collaboration between payers and providers, and the potential for...
David Sand, MD, MBA, chief...
11/13/2024
First Report Managed Care
Richard Lipton, MD
Videos
The Evolving Role of CGRP-targeting Therapies in Migraine Prevention
10/31/2024
Richard Lipton, MD, provides insights on the American Headache Society’s position statement update on calcitonin gene-related peptide (CGRP)-targeting therapies as a first-line option for the prevention of migraine.
Richard Lipton, MD, provides insights on the American Headache Society’s position statement update on calcitonin gene-related peptide (CGRP)-targeting therapies as a first-line option for the prevention of migraine.
Richard Lipton, MD, provides...
10/31/2024
First Report Managed Care
Alexander Spira, MD, PhD
Videos
Unmet Needs in the Treatment and Management of Non–Small Cell Lung Cancer
09/26/2024
Alexander I. Spira, MD, PhD, discusses significant unmet needs in the treatment and management of non–small cell lung cancer (NSCLC).
Alexander I. Spira, MD, PhD, discusses significant unmet needs in the treatment and management of non–small cell lung cancer (NSCLC).
Alexander I. Spira, MD, PhD,...
09/26/2024
First Report Managed Care
Videos
Treatment Options for NSCLC: A Discussion on Coverage, Clinical Outcomes, and Payer Perspectives
09/25/2024
Learn about research developments in 1L therapy for NSCLC patients with EGFR mutations and how outcomes may impact coverage and reimbursement decisions for insurers.
Learn about research developments in 1L therapy for NSCLC patients with EGFR mutations and how outcomes may impact coverage and reimbursement decisions for insurers.
Learn about research...
09/25/2024
First Report Managed Care
Title Card
Videos
Addressing the Root Cause of a Common Ocular Condition: A Virtual Roundtable
09/04/2024
View a roundtable discussion on Demodex blepharitis, a prevalent ocular condition that often goes undiagnosed in patients.
View a roundtable discussion on Demodex blepharitis, a prevalent ocular condition that often goes undiagnosed in patients.
View a roundtable discussion on...
09/04/2024
First Report Managed Care
Jordan Bazinsky
Videos
Addressing Health Disparities and Promoting Equity: The Role of Advanced Imaging Solutions
08/15/2024
Guest expert Jordan Bazinsky discusses the challenges facing the medical imaging industry, the potential of AI and emerging technologies, the role of advanced imaging solutions in promoting health equity, and the key trends and challenges...
Guest expert Jordan Bazinsky discusses the challenges facing the medical imaging industry, the potential of AI and emerging technologies, the role of advanced imaging solutions in promoting health equity, and the key trends and challenges...
Guest expert Jordan Bazinsky...
08/15/2024
First Report Managed Care
Farrukh Awan, MD
Videos
Promising Therapies and Clinical Trials for Chronic Lymphocytic Leukemia
08/14/2024
Farrukh Awan, MD, highlights promising therapies and clinical trials within the field of chronic lymphocytic leukemia (CLL).
Farrukh Awan, MD, highlights promising therapies and clinical trials within the field of chronic lymphocytic leukemia (CLL).
Farrukh Awan, MD, highlights...
08/14/2024
Journal of Clinical Pathways
Hayward
Videos
Evolving Health Care Contact Centers Into Drivers of Value-Based Care
07/31/2024
Discover how health care contact centers can transform into drivers of value-based care through AI, automation, upskilling agents, and rethinking workflows and metrics to improve patient outcomes and population health.
Discover how health care contact centers can transform into drivers of value-based care through AI, automation, upskilling agents, and rethinking workflows and metrics to improve patient outcomes and population health.
Discover how health care contact...
07/31/2024
First Report Managed Care
Lucille Accetta Headshot
Videos
Enhancing Patient Medication Adherence: Insights and Strategies From Asembia 2024
06/11/2024
Lucille Accetta, PharmD, MBA, MSPH, Senior Vice President of CVS Specialty Operations
Key stakeholders in the health care industry gathered to discuss prevalent topics at this year's Asembia annual summit. Medication adherence emerged as one of the most talked-about issues. In a session led by Lucille Accetta, PharmD, MBA,...
Key stakeholders in the health care industry gathered to discuss prevalent topics at this year's Asembia annual summit. Medication adherence emerged as one of the most talked-about issues. In a session led by Lucille Accetta, PharmD, MBA,...
Key stakeholders in the health...
06/11/2024
First Report Managed Care
Melissa Andel, Principal, CommonHealth Solutions, LLC
Videos
Navigating the Impact of the Inflation Reduction Act: Implications for Payers, Patients, and Manufacturers
05/24/2024
Melissa Andel, Principal, CommonHealth Solutions, LLC
Learn about the impacts of the Inflation Reduction Act on payers and patients, highlighting the changes in Medicare benefits and drug coverage coming in 2025 and 2026.
Learn about the impacts of the Inflation Reduction Act on payers and patients, highlighting the changes in Medicare benefits and drug coverage coming in 2025 and 2026.
Learn about the impacts of the...
05/24/2024
First Report Managed Care

Subscribe to our eNewsletters!

First Report Managed Care Newsletter

March 2011 Volume 8 Issue 3

View Issue Archive
Editorial Correspondence

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use